London, United Kingdom

Jennie Yang

This inventor holds 1 USPTO granted patent. Top assignee: Melio Healthcare Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennie Yang. Retrieved from https://idiyas.com/inventor/jennie-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jennie Yang: Inventor in Immune-System Phenotyping.

Introduction

Jennie Yang is an inventor associated with London, United Kingdom. Her patent work focuses on methods for analyzing immune cells and generating standardized immune profiles.

Latest Patents

Yang is associated with 1 patent: “Systems and Methods for Comprehensive and Standardized Immune System Phenotyping and Automated Cell Classification.” The invention describes using fluorescent labeling and full-spectrum flow cytometry to collect cell data, then applying an ensemble machine-learning model to classify cells into immune-cell subpopulations. The resulting profile can report the total count or frequency of each identified cell population.

Career Highlights

Yang is associated with Melio Healthcare Limited. Her listed patent reflects work at the intersection of immunophenotyping, flow cytometry, and automated cell classification.

Collaborations

The provided information lists Jeremy Mason and Eduardo Alves as Yang’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Jennie Yang’s listed invention applies machine learning to immune-cell data, aiming to support comprehensive and standardized immune profiling.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…